Organization
Oncolytics Biotech Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Oncolytics Biotech Inc.
... CANADIAN WEEKLY STOCK REPORT Oncolytics Biotech Inc. (TSX:ONC), Canada's 19th largest Biotechnology company by market cap, has dropped ...
... than the 200-day MAP of CAD2.01, a bearish indicator. 17:00 EDT [-3.7%] Oncolytics Biotech underperforms 86% of the market Its MCap is CAD102.9 million (US$78.4 ...
... CANADIAN DAILY STOCK REPORT Oncolytics Biotech Inc. (TSX:ONC), Canada's 17th largest Biotechnology company by market cap, extended its ...
... CANADIAN WEEKLY STOCK REPORT Oncolytics Biotech Inc. (TSX:ONC), Canada's 17th largest Biotechnology company by market cap, has lifted ...
... CANADIAN DAILY STOCK REPORT Corporate Wire Date: 08 August 2018 00:04 EDT Oncolytics Biotech (ONC) has been issued a new U.S. patent titled "Reoviruses having ...
... 1.1 [1.2]; Dividend Yield of 8.5% [4.1%]. 17:00 EDT [0.1%, 5.3%, CAD1,229] Oncolytics Biotech increases 1.2% on average volume Its MCap is CAD95.5 million (US$73.5 ...
... CANADIAN WEEKLY STOCK REPORT Oncolytics Biotech Inc. (TSX:ONC), Canada's 20th largest Biotechnology company by market cap, has sunk ...
... CALGARY, Alberta and SAN DIEGO, Aug. 03, 2018 (GLOBE NEWSWIRE) -- Oncolytics Biotech® Inc. (Nasdaq: ONCY) (TSX: ONC), currently developing REOLYSIN® (pelareorep), an intravenously delivered ...
... ANNOUNCEMENT [Text] CALGARY, Alberta and SAN DIEGO, July 31, 2018 -- Oncolytics Biotech Inc. (TSX:ONC) (NASDAQ:ONCY), currently developing REOLYSIN (pelareorep), an intravenously delivered immuno-oncolytic virus ...
... CALGARY, Alberta and SAN DIEGO, July 31, 2018 (GLOBE NEWSWIRE) -- Oncolytics Biotech® Inc. (TSX:ONC) (NASDAQ:ONCY), currently developing REOLYSIN® (pelareorep), an intravenously delivered immuno-oncolytic virus ...
Subscribe now for full coverage on Oncolytics Biotech Inc.
Start My Free Trial